Published online Oct 26, 2026. doi: 10.12998/wjcc.125577
Revised: August 7, 2026
Accepted: October 21, 2026
Published online: October 26, 2026
Processing time: 105 Days and 4.2 Hours
Peripheral giant cell granuloma (PGCG) is a reactive lesion of the gingiva or alveolar ridge that usually develops in response to chronic local irritation. Plaque, calculus, trauma, and periodontal inflammation are established contributors, and defective dental prostheses may intensify these effects by creating plaque-retentive areas and repeated soft-tissue injury. This article combines a focused narrative review with an illustrative case to discuss diagnosis, treatment, recur
A 60-year-old man presented with a 1.0 cm × 0.5 cm palatal gingival mass beneath a three-unit ceramometal fixed dental prosthesis in the maxillary anterior region. Clinical examination, radiographic assessment, excisional biopsy, and histopathologic evaluation confirmed PGCG. Management included prosthesis removal, complete excision with curettage, and extraction of a non-restorable abutment tooth. Healing was uneventful, and no recurrence was observed at 6 months. PGCG is a reactive gingival lesion associated with chronic local irritation. This case report illustrates PGCG arising beneath a defective fixed dental prosthesis in a multifactorial inflammatory setting that also included plaque retention and periodontal breakdown. Its value lies in the practical lessons for diagnosis, differential diagnosis, complete excision, elimination of local irritants, prosthodontic redesign, and follow-up to reduce recurrence.
This case supports interpreting a defective prosthesis as a contributing local factor rather than an isolated proven cause. The report highlights the need for clinico
Core Tip: Peripheral giant cell granuloma is a relatively common reactive lesion of the oral cavity that arises exclusively on the gingiva or edentulous alveolar ridge. It is generally regarded as a non-neoplastic proliferation associated with chronic local irritation or trauma, likely originating from the periodontal ligament or periosteum. The report highlights the need for clinicopathologic correlation, cautious causal wording, elimination of local irritants, appropriate prosthodontic redesign when indicated, and follow-up to reduce recurrence.
- Citation: Aljabr AA, Dobaian KS. Peripheral giant cell granuloma associated with dental prostheses: A case report. World J Clin Cases 2026; 14(28): 125577
- URL: https://www.wjgnet.com/2307-8960/full/v14/i28/125577.htm
- DOI: https://dx.doi.org/10.12998/wjcc.125577
Peripheral giant cell granuloma (PGCG) is a reactive lesion that arises exclusively on the gingiva or edentulous alveolar ridge and is generally associated with chronic local irritation or minor trauma[1,2]. Clinically, it usually presents as a red to reddish-purple nodular enlargement that may be sessile or pedunculated and can resemble several other reactive or neoplastic gingival lesions. Because of this overlap in appearance, diagnosis requires correlation of the clinical pre
Dental prostheses may contribute to a chronic inflammatory environment by promoting plaque retention, repeated soft-tissue irritation, poor cleansability, and unfavorable emergence profiles. However, prosthetic factors should be interpreted cautiously as contributory rather than isolated causes. The present case is clinically relevant because it illustrates PGCG developing beneath a defective fixed dental prosthesis in a multifactorial setting that also included periodontal inflammation and compromised abutment teeth[4].
A 60-year-old man presented with a painless swelling on the palatal aspect of the maxillary anterior region.
The patient reported that the lesion had been present for approximately 3 months. He described difficulty cleaning the area and occasional bleeding during toothbrushing. The swelling was located beneath a fixed dental prosthesis and had gradually become more noticeable, although it remained painless.
The medical history was significant for controlled hypertension and controlled type 2 diabetes mellitus treated with losartan and metformin. There was no reported history of systemic giant cell disease or previous similar oral lesions.
The patient was a non-smoker. No relevant family history of oral tumors, metabolic bone disease, or other related conditions was reported.
Intraoral examination revealed a sessile, exophytic, erythematous nodular lesion on the palatal gingiva of the maxillary anterior region. The lesion measured approximately 1.0 cm × 0.5 cm, was firm on palpation, and had a lobulated surface. It was located directly beneath the pontic-connector region of a three-unit ceramometal fixed dental prosthesis extending from tooth #11 to tooth #22. The prosthesis showed marginal discrepancy, an overcontoured plaque-retentive emergence profile, and defective cervical adaptation at the abutment margins. The adjacent gingiva was inflamed and edematous (Figure 1).
No routine hematologic or biochemical abnormalities were documented. Because the lesion was solitary and the histopathologic findings were typical for PGCG, biochemical evaluation for hyperparathyroidism, including serum calcium, phosphate, and parathyroid hormone levels, was not pursued[5]. Histopathologic examination of the excised specimen showed a non-encapsulated lesion beneath stratified squamous epithelium with a highly cellular and vascular connective tissue stroma containing numerous multinucleated giant cells, hemorrhage, hemosiderin deposition, and inflammatory infiltrate, consistent with PGCG.
Periapical radiographs demonstrated generalized horizontal bone loss consistent with chronic periodontitis, together with severe vertical bone loss around the involved abutment teeth. Widening of the periodontal ligament space was also noted. No convincing central osteolytic lesion or distinct cup-shaped resorption was identified.
The case was assessed through clinicopathologic correlation involving prosthodontic/periodontal clinical evaluation, radiographic interpretation, and histopathologic examination of the excised tissue (Figure 2). This integrated assessment supported a reactive peripheral lesion rather than a primary central bony process.
PGCG of the palatal gingiva associated with a defective fixed dental prosthesis in a multifactorial inflammatory setting.
Treatment focused on elimination of local irritants and definitive surgical management. The fixed dental prosthesis was removed to allow full visualization of the lesion and proper assessment of the abutment teeth (Figure 3A). Under local anesthesia with 2% lidocaine containing 1:100000 epinephrine, the lesion was completely excised down to the periosteum, and the base was curetted to reduce the possibility of residual lesion tissue (Figure 3B). Tooth #22 was extracted during the same procedure because it was non-restorable and periodontally compromised. The specimen was fixed in 10% formalin and submitted for histopathologic examination (Figure 4). Postoperatively, the patient received ibuprofen 400 mg as needed, chlorhexidine gluconate 0.12% mouthwash, and oral hygiene instructions.
At 20 days postoperatively, the surgical site showed satisfactory healing with healthy pink mucosa and no evidence of infection or residual lesion (Figure 5). A transitional acrylic removable partial denture was delivered to restore function and esthetics during healing and subsequent prosthetic planning. At 6-month follow-up, the surgical site remained clinically stable with no evidence of recurrence. The patient reported satisfactory function with the transitional prosthesis and remained under periodic review for definitive rehabilitation and maintenance.
The narrative review was structured and reported with reference to the Scale for the Assessment of Narrative Review Articles[6], and the case was documented in line with the CARE reporting guidelines[7]. PGCG should be interpreted as a reactive lesion arising within a multifactorial local inflammatory environment rather than being attributed to a single isolated cause (Table 1). In the present case, the lesion developed beneath a defective fixed dental prosthesis; however, plaque retention, gingival inflammation, periodontal destruction, and compromised abutment teeth were also present and likely contributed to lesion development (Table 2). Therefore, the prosthesis is best considered a contributory local irritative factor rather than definitive proof of causation.
| Category | Examples | Clinical relevance |
| Biofilm-related factors | Plaque, calculus, food impaction | Sustain chronic gingival inflammation |
| Prosthetic/restorative factors | Overhanging margins, poor marginal adaptation, rough surfaces, defective pontic design, poor emergence profile | Increase plaque retention and/or soft tissue trauma |
| Periodontal factors | Chronic periodontitis, deep inflammation around abutment teeth | May contribute to a reactive gingival environment |
| Traumatic factors | Repetitive mechanical irritation, impinging prosthetic components | Promote persistent local injury |
| Systemic/contextual contributors | Hormonal changes, xerostomia, impaired hygiene access | May increase susceptibility, though usually not sufficient alone |
| Lesion | Typical clinical clues | Role of histopathology |
| Peripheral giant cell granuloma | Red-purple gingival/alveolar ridge nodule; may ulcerate; reactive setting | Confirms multinucleated giant cells in vascular stroma with hemorrhage/hemosiderin |
| Pyogenic granuloma | Soft, highly vascular, bleeds easily | Distinguishes capillary granulation tissue pattern from PGCG |
| Peripheral ossifying fibroma | Firmer, often paler, gingival mass | Demonstrates fibrous proliferation with mineralized material |
| Fibroma | Firm, mucosal-colored nodule | Shows dense fibrous connective tissue |
| Brown tumor of hyperparathyroidism | Giant cell lesion pattern with systemic metabolic context | Requires clinicopathologic and biochemical correlation |
| Plasma cell gingivitis | Diffuse erythematous/plasma cell-rich gingival changes | Histology and, if needed, adjunctive workup aid exclusion of mimics |
| Hematologic/neoplastic lesions (e.g., plasmacytoma, leukemia-related enlargement) | Atypical appearance, systemic signs, rapid progression, or unusual site/course | Biopsy is essential; immunohistochemistry may be required |
This case also highlights the importance of clinicopathologic correlation. Clinically, PGCG may resemble pyogenic granuloma, peripheral ossifying fibroma, and fibroma[8,9]; in selected situations, less common systemic or neoplastic lesions must also be considered[10,11]. Histopathologic confirmation was therefore essential. Central giant cell granuloma was also considered in the broader differential diagnosis[12], but the lesion was centered in soft tissue and radiographs did not show a convincing central osteolytic process. The observed bone loss and widening of the periodontal ligament space were more consistent with chronic periodontitis and pressure-related local effects than with a primary intraosseous giant cell lesion (Table 2).
From a therapeutic standpoint, successful management requires not only complete excision but also elimination of local irritants and appropriate prosthodontic correction. Curettage of the base and removal of compromised local factors are important because recurrence has been reported when irritants persist[13,14]. The absence of recurrence during the 6-month follow-up in this patient supports the value of combined surgical management, local debridement, and prosthetic reassessment[15] (Table 3).
| Time point | Event |
| Day 0 | Initial clinical assessment; lesion identified beneath the defective FDP; periapical radiographs obtained; FDP removed; complete excision with curettage performed; non-restorable tooth #22 extracted during the same procedure |
| Day 20 | Suture removal; favorable healing observed; transitional acrylic removable partial denture delivered |
| 6 months | No clinical recurrence; continued maintenance and definitive prosthetic planning |
PGCG is a reactive gingival lesion that should be interpreted within a multifactorial setting of chronic local irritation. Defective dental prostheses may contribute to plaque retention and repeated mucosal trauma, but they should be regarded as contributory rather than sole causative factors. Accurate diagnosis depends on correlation of clinical, radiographic, and histopathologic findings. Effective management requires complete excision, elimination of local irritants, appropriate prosthodontic redesign when necessary, and follow-up to detect recurrence.
This case was managed in accordance with the ethical principles of the Declaration of Helsinki[16]. The authors thank the patient for consenting to publication of the clinical details and images. They also acknowledge the contribution of the clinical and pathology teams involved in the diagnosis and management of this case.
| 1. | Giansanti JS, Waldron CA. Peripheral giant cell granuloma: review of 720 cases. J Oral Surg. 1969;27:787-791. [PubMed] |
| 2. | Katsikeris N, Kakarantza-Angelopoulou E, Angelopoulos AP. Peripheral giant cell granuloma. Clinicopathologic study of 224 new cases and review of 956 reported cases. Int J Oral Maxillofac Surg. 1988;17:94-99. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 101] [Cited by in RCA: 92] [Article Influence: 2.4] [Reference Citation Analysis (0)] |
| 3. | Chrcanovic BR, Gomes CC, Gomez RS. Peripheral giant cell granuloma: An updated analysis of 2824 cases reported in the literature. J Oral Pathol Med. 2018;47:454-459. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 54] [Cited by in RCA: 44] [Article Influence: 5.5] [Reference Citation Analysis (1)] |
| 4. | Ozden FO, Ozden B, Kurt M, Gündüz K, Günhan O. Peripheral giant cell granuloma associated with dental implants: a rare case report. Int J Oral Maxillofac Implants. 2009;24:1153-1156. [PubMed] |
| 5. | Neville BW, Damm DD, Allen CM, Chi AC. Oral and Maxillofacial Pathology. 4th ed. Elsevier. 2016. Available from: https://shop.elsevier.com/books/oral-and-maxillofacial-pathology/neville/978-1-4557-7052-6. |
| 6. | Baethge C, Goldbeck-Wood S, Mertens S. SANRA-a scale for the quality assessment of narrative review articles. Res Integr Peer Rev. 2019;4:5. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 1648] [Cited by in RCA: 1878] [Article Influence: 268.3] [Reference Citation Analysis (5)] |
| 7. | Riley DS, Barber MS, Kienle GS, Aronson JK, von Schoen-Angerer T, Tugwell P, Kiene H, Helfand M, Altman DG, Sox H, Werthmann PG, Moher D, Rison RA, Shamseer L, Koch CA, Sun GH, Hanaway P, Sudak NL, Kaszkin-Bettag M, Carpenter JE, Gagnier JJ. CARE guidelines for case reports: explanation and elaboration document. J Clin Epidemiol. 2017;89:218-235. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 1559] [Cited by in RCA: 1385] [Article Influence: 153.9] [Reference Citation Analysis (0)] |
| 8. | Kfir Y, Buchner A, Hansen LS. Reactive lesions of the gingiva. A clinicopathological study of 741 cases. J Periodontol. 1980;51:655-661. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 98] [Cited by in RCA: 94] [Article Influence: 2.0] [Reference Citation Analysis (2)] |
| 9. | Zhang W, Chen Y, An Z, Geng N, Bao D. Reactive gingival lesions: a retrospective study of 2,439 cases. Quintessence Int. 2007;38:103-110. [PubMed] |
| 10. | Gerardi D, Torge D, Bernardi S, Burdo P, Piattelli M, Varvara G. Plasma Cell Gingivitis: Clinical Presentation, Histopathologic Correlation, and Therapeutic Challenges. Clin Pract. 2025;15:158. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in RCA: 2] [Reference Citation Analysis (0)] |
| 11. | Bernardi S, Bianchi S, Lupi E, Gerardi D, Macchiarelli G, Varvara G. Plasmacytoma in the Maxillary Jaw: A Diagnostic and Therapeutic Challenge. Hematol Rep. 2024;16:22-31. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 2] [Cited by in RCA: 5] [Article Influence: 2.5] [Reference Citation Analysis (0)] |
| 12. | Motamedi MH, Eshghyar N, Jafari SM, Lassemi E, Navi F, Abbas FM, Khalifeh S, Eshkevari PS. Peripheral and central giant cell granulomas of the jaws: a demographic study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;103:e39-e43. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 80] [Cited by in RCA: 64] [Article Influence: 3.4] [Reference Citation Analysis (1)] |
| 13. | Lester SR, Cordell KG, Rosebush MS, Palaiologou AA, Maney P. Peripheral giant cell granulomas: a series of 279 cases. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;118:475-482. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 35] [Cited by in RCA: 35] [Article Influence: 2.9] [Reference Citation Analysis (0)] |
| 14. | Chaparro-Avendaño AV, Berini-Aytés L, Gay-Escoda C. Peripheral giant cell granuloma. A report of five cases and review of the literature. Med Oral Patol Oral Cir Bucal. 2005;10:53-7; 48. [PubMed] |
| 15. | Mannem S, Chava VK. Management of an unusual peripheral giant cell granuloma: A diagnostic dilemma. Contemp Clin Dent. 2012;3:93-96. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 7] [Cited by in RCA: 11] [Article Influence: 0.8] [Reference Citation Analysis (0)] |
| 16. | Deutsch E. The Declaration of Helsinki revised in Edinburgh 2000 clarified strengthened and or extended. Clin Res Regul Aff. 2001;18:113-122. |